The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 ...

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...

A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 ...

Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...